Global Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Forecast 2024-2030- Product Image

Sale

Global Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Forecast 2024-2030

Report
196 Pages
March 2024
Region: Global
360iResearch™
ID: 5305520

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Alopecia Treatment Market size was estimated at USD 3.26 billion in 2023, USD 3.53 billion in 2024, and is expected to grow at a CAGR of 8.27% to reach USD 5.69 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alopecia Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alopecia Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Treatment Market, highlighting leading vendors and their innovative profiles. These include Aclaris Therapeutics, Inc., AnaptysBio Inc., BiologicsMD, Inc., Cipla, Inc., Cirrus Hair Centers, Curallux, LLC, Daiichi Sankyo Inc., DR. KURT WOLFF GMBH & CO. KG, Dr. Reddy's Laboratories Ltd, Eli Lilly and Company, Fagron NV by Omega Pharma, Follica, Inc., HCell Inc., iGrow Laser, iRestore Hair Growth System, Johnson & Johnson Services, Inc, KNOW Bio LLC, Pfizer Inc., RepliCel Life Sciences Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Theradome GB, Transitions Hair Pty Ltd., Viviscal, and Zocdoc, Inc.

Market Segmentation & Coverage

This research report categorizes the Alopecia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Disease Type
- Alopecia Areata
- Alopecia Totalis
- Alopecia Universalis
- Androgenetic Alopecia
- Cicatricial Alopecia
- Traction Alopecia
Route of Administration
- Injectable
- Oral
- Topical
Gender
- Female
- Male
Treatment Option
- Anthralin
- Corticosteroid
- JAK Inhibitors
- Methotrexate
- Topical Immunotherapy
End User
- Dermatology Clinics
- Homecare Setting

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Alopecia Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alopecia Treatment Market?
What are the technology trends and regulatory frameworks in the Alopecia Treatment Market?
What is the market share of the leading vendors in the Alopecia Treatment Market?
Which modes and strategic moves are suitable for entering the Alopecia Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Alopecia Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of androgenetic alopecia and alopecia areata diseases
5.1.1.2. Growing awareness about hair loss and transplantation
5.1.1.3. Rise in income levels and increased healthcare spending
5.1.2. Restraints
5.1.2.1. Lack of reimbursement policies for alopecia treatments
5.1.3. Opportunities
5.1.3.1. Emergence of new alopecia areata treatments and therapeutics
5.1.3.2. Rising investments and expansion of hair transplant clinics
5.1.4. Challenges
5.1.4.1. Issues associated with efficacy and side-effects related to some hair loss treatment therapies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Alopecia Treatment Market, by Disease Type

6.1. Introduction
6.2. Alopecia Areata
6.3. Alopecia Totalis
6.4. Alopecia Universalis
6.5. Androgenetic Alopecia
6.6. Cicatricial Alopecia
6.7. Traction Alopecia

7. Alopecia Treatment Market, by Route of Administration

7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Topical

8. Alopecia Treatment Market, by Gender

8.1. Introduction
8.2. Female
8.3. Male

9. Alopecia Treatment Market, by Treatment Option

9.1. Introduction
9.2. Anthralin
9.3. Corticosteroid
9.4. JAK Inhibitors
9.5. Methotrexate
9.6. Topical Immunotherapy

10. Alopecia Treatment Market, by End User

10.1. Introduction
10.2. Dermatology Clinics
10.3. Homecare Setting

11. Americas Alopecia Treatment Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Alopecia Treatment Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Alopecia Treatment Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. Aclaris Therapeutics, Inc.
15.1.2. AnaptysBio Inc.
15.1.3. BiologicsMD, Inc.
15.1.4. Cipla, Inc.
15.1.5. Cirrus Hair Centers
15.1.6. Curallux, LLC
15.1.7. Daiichi Sankyo Inc.
15.1.8. DR. KURT WOLFF GMBH & CO. KG
15.1.9. Dr. Reddy's Laboratories Ltd
15.1.10. Eli Lilly and Company
15.1.11. Fagron NV by Omega Pharma
15.1.12. Follica, Inc.
15.1.13. HCell Inc.
15.1.14. iGrow Laser
15.1.15. iRestore Hair Growth System
15.1.16. Johnson & Johnson Services, Inc
15.1.17. KNOW Bio LLC
15.1.18. Pfizer Inc.
15.1.19. RepliCel Life Sciences Inc.
15.1.20. Sun Pharmaceutical Industries Ltd.
15.1.21. Teva Pharmaceutical Industries Ltd
15.1.22. Theradome GB
15.1.23. Transitions Hair Pty Ltd.
15.1.24. Viviscal
15.1.25. Zocdoc, Inc.
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. ALOPECIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ALOPECIA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ALOPECIA TREATMENT MARKET DYNAMICS
FIGURE 7. ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 8. ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
FIGURE 12. ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2030 (%)
FIGURE 14. ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ALOPECIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 6. ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ALOPECIA TREATMENT MARKET SIZE, BY CICATRICIAL ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ALOPECIA TREATMENT MARKET SIZE, BY TRACTION ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 13. ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ALOPECIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 17. ALOPECIA TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ALOPECIA TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 20. ALOPECIA TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ALOPECIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ALOPECIA TREATMENT MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. ALOPECIA TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. ALOPECIA TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. ALOPECIA TREATMENT MARKET SIZE, BY HOMECARE SETTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 47. CANADA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 48. CANADA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 53. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 74. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 75. CHINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 79. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 80. INDIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 89. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 90. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 119. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 120. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 135. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 136. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 140. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 141. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 145. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 146. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 155. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 156. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 165. ITALY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 166. ITALY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 180. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 181. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 185. POLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 186. POLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 190. QATAR ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 191. QATAR ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 210. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 211. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 225. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 238. ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 239. ALOPECIA TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

Aclaris Therapeutics, Inc.
AnaptysBio Inc.
BiologicsMD, Inc.
Cipla, Inc.
Cirrus Hair Centers
Curallux, LLC
Daiichi Sankyo Inc.
DR. KURT WOLFF GMBH & CO. KG
Dr. Reddy's Laboratories Ltd
Eli Lilly and Company
Fagron NV by Omega Pharma
Follica, Inc.
HCell Inc.
iGrow Laser
iRestore Hair Growth System
Johnson & Johnson Services, Inc
KNOW Bio LLC
Pfizer Inc.
RepliCel Life Sciences Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd
Theradome GB
Transitions Hair Pty Ltd.
Viviscal
Zocdoc, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	196
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.53 Billion
Forecasted Market Value ( USD ) by 2030	$ 5.69 Billion
Compound Annual Growth Rate	8.2%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Forecast 2024-2030

Global Alopecia Market Size, Share & Trends Analysis Report by Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), Treatment, Gender, Sales Channel, End-use, Region, and Segment Forecasts, 2024-2030

Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Gender (Male, Female), By Treatment (Pharmaceuticals, Devices), By End-use (Dermatology Clinics, Homecare Settings), By Sales Channel, And Segment Forecasts, 2024 - 2030

Alopecia Areata Global Market Report 2024

Alopecia Global Market Report 2024

About the Alopecia Drug Market